Opdualag Side Effects
Generic name: nivolumab / relatlimab
Medically reviewed by Drugs.com. Last updated on Sep 16, 2024.
Note: This document provides detailed information about Opdualag Side Effects associated with nivolumab / relatlimab. Some dosage forms listed on this page may not apply specifically to the brand name Opdualag.
Applies to nivolumab / relatlimab: intravenous solution.
Serious side effects of Opdualag
Along with its needed effects, nivolumab/relatlimab may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor or nurse immediately if any of the following side effects occur while taking nivolumab / relatlimab:
More common side effects
- back pain
- black, tarry stools
- blistering, peeling, or loosening of the skin
- chest pain or tightness
- chills
- constipation
- cough
- dark urine
- depressed mood
- diarrhea
- dry skin and hair
- feeling cold
- fever
- flushing
- hair loss
- headache
- hoarseness or husky voice
- itching
- joint or muscle pain
- light-colored stools
- muscle cramps and stiffness
- nausea and vomiting
- nervousness
- painful or difficult urination
- red irritated eyes
- red skin lesions, often with a purple center
- sensitivity to heat
- slowed heartbeat
- sore throat
- sores, ulcers, or white spots in the mouth or on the lips
- stomach cramps, pain, or tenderness
- sweating
- swollen glands
- trouble breathing
- trouble sleeping
- unusual bleeding or bruising
- unusual tiredness and weakness
- upper right abdominal or stomach pain
- watery or bloody diarrhea
- weight loss or gain
- yellow eyes and skin
Less common side effects
- bloody or cloudy urine
- chest discomfort
- darkening of the skin
- decrease in urine output or decrease in urine-concentrating ability
- dizziness
- fainting
- fast heartbeat
- loss of appetite
- mental depression
- muscle spasms
- pain or discomfort in the arms, jaw, back or neck
- pale skin
- seeing flashes or sparks of light
- seeing floating spots before the eyes, or a veil or curtain appearing across part of vision
- skin rash
- swelling of the face, feet, or lower legs
- swelling or redness in the joints
- thickening of bronchial secretions
Rare side effects
- anxiety
- back, leg, or stomach pains
- bleeding gums
- bloating
- blue or pale skin
- blurred vision
- burning, tingling, numbness or pain in the hands, arms, feet, or legs
- burning feeling in the chest or stomach
- chest pain, possibly moving to the left arm, neck, or shoulder
- confusion
- difficulty in breathing, chewing, swallowing, or talking
- double vision
- drooping eyelids
- drowsiness
- dry mouth
- eye pain
- fruit-like breath odor
- heavier menstrual periods
- inability to move the arms and legs
- increased hunger
- increased thirst
- increased urination
- indigestion
- irritability
- loss of consciousness
- muscle weakness
- nosebleeds
- pains in the stomach, side, or abdomen, possibly radiating to the back
- pinpoint red spots on the skin
- redness, soreness, or itching skin
- redness of the eye
- seizures
- sensation of pins and needles
- sensitivity of the eyes to light
- stabbing pain
- stiff neck or back
- stomach upset
- sudden numbness and weakness in the arms and legs
- swollen, painful, or tender lymph glands in the neck, armpit, or groin
- tearing
Other side effects of Opdualag
Some side effects of nivolumab / relatlimab may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.
Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
More common side effects
- decreased appetite
For healthcare professionals
Applies to nivolumab / relatlimab: intravenous solution.
General adverse events
The most frequent (greater than 1%) serious adverse events reported in clinical trials were adrenal insufficiency, anemia, colitis, pneumonia, acute myocardial infarction, back pain, diarrhea, myocarditis, and pneumonitis. The most common (greater than 20%) adverse reactions were musculoskeletal pain, fatigue, rash, pruritus, and diarrhea.[Ref]
Cardiovascular
- Frequency not reported: Myocarditis[Ref]
Dermatologic
Endocrine
- Very common (10% or more): Hypothyroidism (17%)
- Frequency not reported: Adrenal insufficiency
Gastrointestinal
- Very common (10% or more): Diarrhea (24%), nausea (17%)[Ref]
Hematologic
- Very common (10% or more): Decreased hemoglobin (37%), decreased lymphocytes (32%)[Ref]
Hepatic
- Very common (10% or more): Increased AST (30%), increased ALT (26%)
- Frequency not reported: Hepatitis[Ref]
Metabolic
- Very common (10% or more): Decreased appetite (15%), increased alkaline phosphatase (19%)[Ref]
Musculoskeletal
- Very common (10% or more): Musculoskeletal pain (45%)[Ref]
Nervous system
- Very common (10% or more): Headache (18%)[Ref]
Other
- Very common (10% or more): Fatigue (39%), decreased sodium (24%)[Ref]
Renal
- Very common (10% or more): Increased creatinine (19%)[Ref]
Respiratory
- Very common (10% or more): Cough (15%)
- Common (1% to 10%): Pneumonitis[Ref]
See also:
Opdivo
Opdivo is used to treat many cancers, such as melanoma, non-small cell lung cancer, malignant ...
Keytruda
Keytruda is used to treat multiple types of cancer such as melanoma, non-small cell lung cancer ...
Opdivo Qvantig
Opdivo Qvantig is used to treat adults with melanoma, non-small cell lung cancer, renal cell ...
Tecentriq
Tecentriq (atezolizumab) is a monoclonal antibody used to treat non-small cell lung cancer, small ...
Yervoy
Yervoy (ipilimumab) is a cancer treatment used for lung cancer, melanoma, renal cell carcinoma ...
Interferon alfa-2b
Interferon alfa-2b systemic is used for angioblastoma, condylomata acuminata, conjunctival ...
Dacarbazine
Dacarbazine systemic is used for hodgkin's lymphoma, melanoma, melanoma, metastatic
Ipilimumab
ipilimumab (Yervoy) is an immunotherapy used for melanoma, renal cell carcinoma, non-small cell ...
Atezolizumab
Atezolizumab (Tecentriq) is a type of immunotherapy drug that helps the body's immune system to ...
References
1. (2023) "Product Information. Opdualag (nivolumab-relatlimab)." (Obsolete) Bristol-Myers Squibb Australia Pty Ltd, 2
2. (2022) "Product Information. Opdualag (nivolumab-relatlimab)." Bristol-Myers Squibb
More about Opdualag (nivolumab / relatlimab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: antineoplastic combinations
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Opdualag side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.
